Boston Scientific receives FDA clearance for fourth-gen DBS system

Boston Scientific has received Food and Drug Administration (FDA) approval of its fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: